Omnix Medical

Resistance is not an option.

Jerusalem, Israel · Founded 2015 · $33.5M raised

Headquarters
Jerusalem
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$33.5M
Last Round
$25.0M Series COct 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Omnix Medical is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Jerusalem, Israel, dedicated to developing novel antibiotic agents against drug-resistant bacterial infections. The company's lead compound, OMN6, is a first-in-class antimicrobial peptide engineered for stability and selectivity, currently in Phase II clinical trials targeting sepsis and hospital-acquired infections. Omnix has raised over $33 million in funding from investors including Harel Insurance & Finance and the European Innovation Council Fund, and has received EU Horizon 2020 grants.

Summary

Omnix Medical is a Biotech company based in Jerusalem, Israel, founded in 2015. It has raised $33.5M in total across 2 rounds, most recently a $25.0M Series C round in Oct 2025. Investors include Entrée Capital, Tal Ventures and Harel Insurance & Finance.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries COct 2025
$25.0M

Sign up to see all 2 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Omnix Medical on Indexed.vc
<a href="https://indexed.vc/companies/omnix-medical"><img src="https://indexed.vc/api/badge/company/omnix-medical" alt="Omnix Medical on Indexed.vc" width="260" height="76" /></a>